STAAR Surgical Net Worth
STAAR Surgical Net Worth Breakdown | STAA |
STAAR Surgical Net Worth Analysis
STAAR Surgical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STAAR Surgical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STAAR Surgical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STAAR Surgical's net worth analysis. One common approach is to calculate STAAR Surgical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STAAR Surgical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STAAR Surgical's net worth. This approach calculates the present value of STAAR Surgical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STAAR Surgical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STAAR Surgical's net worth. This involves comparing STAAR Surgical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STAAR Surgical's net worth relative to its peers.
Enterprise Value |
|
To determine if STAAR Surgical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STAAR Surgical's net worth research are outlined below:
| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| STAAR Surgical is unlikely to experience financial distress in the next 2 years | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: LMR Partners LLP Buys 743 Shares of STAAR Surgical |
STAAR Surgical Quarterly Good Will |
|
STAAR Surgical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STAAR Surgical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STAAR Surgical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know STAAR Surgical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STAAR Surgical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STAAR Surgical backward and forwards among themselves. STAAR Surgical's institutional investor refers to the entity that pools money to purchase STAAR Surgical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Defender Capital, Llc. | 2024-09-30 | 677.6 K | Northern Trust Corp | 2024-09-30 | 627.8 K | Kayne Anderson Rudnick Investment Management Llc | 2024-06-30 | 592.6 K | Ensign Peak Advisors Inc | 2024-09-30 | 529.2 K | Yunqi Capital Ltd | 2024-09-30 | 515.3 K | American Capital Management Inc | 2024-09-30 | 512.8 K | Armistice Capital, Llc | 2024-09-30 | 496.5 K | Royal Bank Of Canada | 2024-06-30 | 470.1 K | Bank Of America Corp | 2024-06-30 | 460.8 K | Broadwood Capital Inc | 2024-09-30 | 10.8 M | Blackrock Inc | 2024-06-30 | 7.5 M |
Follow STAAR Surgical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.31 B.Market Cap |
|
Project STAAR Surgical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.11 | 0.12 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.11 | 0.11 |
When accessing STAAR Surgical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STAAR Surgical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STAAR Surgical's profitability and make more informed investment decisions.
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.
Evaluate STAAR Surgical's management efficiency
STAAR Surgical has return on total asset (ROA) of 0.0339 % which means that it generated a profit of $0.0339 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.054 %, meaning that it created $0.054 on every $100 dollars invested by stockholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.12. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 129.6 M, whereas Non Currrent Assets Other are forecasted to decline to about 1.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.48 | 5.75 | |
| Tangible Book Value Per Share | 5.43 | 5.71 | |
| Enterprise Value Over EBITDA | 112.02 | 117.62 | |
| Price Book Value Ratio | 16.67 | 26.66 | |
| Enterprise Value Multiple | 112.02 | 117.62 | |
| Price Fair Value | 16.67 | 26.66 | |
| Enterprise Value | 109.5 M | 104.1 M |
Evaluating the management effectiveness of STAAR Surgical allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The STAAR Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 3.2786 | Revenue 341.2 M | Quarterly Revenue Growth 0.103 | Revenue Per Share 6.962 | Return On Equity 0.054 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STAAR Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STAAR Surgical Corporate Filings
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 31st of October 2024 An amendment to a previously filed Form 8-K | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 19th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
STAAR Surgical Earnings per Share Projection vs Actual
When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.